We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Teva Strikes $24M Deal To Exit Nexium Pay-For-Delay Suit

Law360, San Diego (April 2, 2015, 10:47 PM EDT) -- Class action plaintiffs in a pay-for-delay case over generic versions of AstraZeneca PLC’s heartburn drug Nexium disclosed on Thursday a $24 million settlement freeing Teva Pharmaceutical Industries Ltd. from the case,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.